The good news in prescription healthcare is that there are a lot of new medications entering the market that are having a positive impact in treating disease.
Others, like some of the new statin drugs that have been introduced (Praluent, Sanofi, etc). are entering a very competitive marketplace with several lower cost alternatives that work very well in treating cholesterol.
Typically, there is a lot of excitement and enthusiasm among patients and prescribers when new drugs are released. For this reason, it is important to have thorough evaluation criteria established prior to approval so you aren’t approving medications that have alternatives that work just as well, only at a much higher price. MedTrak controls this through our 90 Day Drug Review Policy for all new drugs. This policy makes sure that we have the appropriate clinical criteria in place before approving these medications and incurring unexpected costs to your plan. To see our policy, click here.
Back to all Industry Insights